Long-term memory CD8+ T cells specific for SARS-CoV-2 in individuals who received the BNT162b2 mRNA vaccine
mRNA vaccines have been shown to prevent SARS-CoV-2 infection and reduce hospitalization and mortality rates. Here, the authors show evidence of long-term memory CD8 + T cells in individuals who received the BNT162b2 SARS-CoV-2 mRNA vaccine.
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-09-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-022-32989-4 |
_version_ | 1811273813029027840 |
---|---|
author | Nozomi Kuse Yu Zhang Takayuki Chikata Hung The Nguyen Shinichi Oka Hiroyuki Gatanaga Masafumi Takiguchi |
author_facet | Nozomi Kuse Yu Zhang Takayuki Chikata Hung The Nguyen Shinichi Oka Hiroyuki Gatanaga Masafumi Takiguchi |
author_sort | Nozomi Kuse |
collection | DOAJ |
description | mRNA vaccines have been shown to prevent SARS-CoV-2 infection and reduce hospitalization and mortality rates. Here, the authors show evidence of long-term memory CD8 + T cells in individuals who received the BNT162b2 SARS-CoV-2 mRNA vaccine. |
first_indexed | 2024-04-12T23:05:57Z |
format | Article |
id | doaj.art-b059fd47ef9e4e3e945a1bbbe348a710 |
institution | Directory Open Access Journal |
issn | 2041-1723 |
language | English |
last_indexed | 2024-04-12T23:05:57Z |
publishDate | 2022-09-01 |
publisher | Nature Portfolio |
record_format | Article |
series | Nature Communications |
spelling | doaj.art-b059fd47ef9e4e3e945a1bbbe348a7102022-12-22T03:12:55ZengNature PortfolioNature Communications2041-17232022-09-0113111110.1038/s41467-022-32989-4Long-term memory CD8+ T cells specific for SARS-CoV-2 in individuals who received the BNT162b2 mRNA vaccineNozomi Kuse0Yu Zhang1Takayuki Chikata2Hung The Nguyen3Shinichi Oka4Hiroyuki Gatanaga5Masafumi Takiguchi6Division of International Collaboration Research and Tokyo laboratory, Joint Research Center for Human Retrovirus Infection, Kumamoto UniversityDivision of International Collaboration Research and Tokyo laboratory, Joint Research Center for Human Retrovirus Infection, Kumamoto UniversityDivision of International Collaboration Research and Tokyo laboratory, Joint Research Center for Human Retrovirus Infection, Kumamoto UniversityDivision of International Collaboration Research and Tokyo laboratory, Joint Research Center for Human Retrovirus Infection, Kumamoto UniversityDivision of International Collaboration Research and Tokyo laboratory, Joint Research Center for Human Retrovirus Infection, Kumamoto UniversityDivision of International Collaboration Research and Tokyo laboratory, Joint Research Center for Human Retrovirus Infection, Kumamoto UniversityDivision of International Collaboration Research and Tokyo laboratory, Joint Research Center for Human Retrovirus Infection, Kumamoto UniversitymRNA vaccines have been shown to prevent SARS-CoV-2 infection and reduce hospitalization and mortality rates. Here, the authors show evidence of long-term memory CD8 + T cells in individuals who received the BNT162b2 SARS-CoV-2 mRNA vaccine.https://doi.org/10.1038/s41467-022-32989-4 |
spellingShingle | Nozomi Kuse Yu Zhang Takayuki Chikata Hung The Nguyen Shinichi Oka Hiroyuki Gatanaga Masafumi Takiguchi Long-term memory CD8+ T cells specific for SARS-CoV-2 in individuals who received the BNT162b2 mRNA vaccine Nature Communications |
title | Long-term memory CD8+ T cells specific for SARS-CoV-2 in individuals who received the BNT162b2 mRNA vaccine |
title_full | Long-term memory CD8+ T cells specific for SARS-CoV-2 in individuals who received the BNT162b2 mRNA vaccine |
title_fullStr | Long-term memory CD8+ T cells specific for SARS-CoV-2 in individuals who received the BNT162b2 mRNA vaccine |
title_full_unstemmed | Long-term memory CD8+ T cells specific for SARS-CoV-2 in individuals who received the BNT162b2 mRNA vaccine |
title_short | Long-term memory CD8+ T cells specific for SARS-CoV-2 in individuals who received the BNT162b2 mRNA vaccine |
title_sort | long term memory cd8 t cells specific for sars cov 2 in individuals who received the bnt162b2 mrna vaccine |
url | https://doi.org/10.1038/s41467-022-32989-4 |
work_keys_str_mv | AT nozomikuse longtermmemorycd8tcellsspecificforsarscov2inindividualswhoreceivedthebnt162b2mrnavaccine AT yuzhang longtermmemorycd8tcellsspecificforsarscov2inindividualswhoreceivedthebnt162b2mrnavaccine AT takayukichikata longtermmemorycd8tcellsspecificforsarscov2inindividualswhoreceivedthebnt162b2mrnavaccine AT hungthenguyen longtermmemorycd8tcellsspecificforsarscov2inindividualswhoreceivedthebnt162b2mrnavaccine AT shinichioka longtermmemorycd8tcellsspecificforsarscov2inindividualswhoreceivedthebnt162b2mrnavaccine AT hiroyukigatanaga longtermmemorycd8tcellsspecificforsarscov2inindividualswhoreceivedthebnt162b2mrnavaccine AT masafumitakiguchi longtermmemorycd8tcellsspecificforsarscov2inindividualswhoreceivedthebnt162b2mrnavaccine |